fda compounding semaglutide enforcement october 2025 glp-1 news issued 25 warning letters to telehealth companies for false Compounded "semaglutide" is not FDA-approved

What "Per Month" Looks Like Different research protocols consume different total amounts, so a strict "per month" number depends entirely on the protocol

These actions align with the types of tissue repair in bone, cartilage, and muscle that are essential in managing OA [1]

No dose adjustment is needed when using both

Xia et al., 2022)

Patients should be aware of important warning signs requiring medical attention: persistent severe abdominal pain with or without vomiting (possible pancreatitis), right upper quadrant pain/fever/jaundice (possible gallbladder disease), reduced urination or dizziness (possible dehydration/kidney issues), visual changes (especially in diabetes patients), or allergic reactions